On April 5, 2022, NewGLAB Pharma CO.,LTD closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,383 KRW | -27.44% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 47.12M | |
-2.29% | 370B | |
+22.71% | 1.95B | |
-18.03% | 1.06B | |
+66.81% | 792M | |
+9.13% | 780M | |
-11.48% | 765M | |
+43.52% | 669M | |
-29.73% | 349M | |
-10.21% | 287M |
- Stock Market
- Equities
- A214870 Stock
- News NewGLAB Pharma CO.,LTD
- NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm